Atsushi Uno

Atsushi has been engaged in research and development of DDS technology for nucleic acid drugs for 16 years at a bio-venture company and experienced a series of processes from basic research and development to clinical trials for the creation of nucleic acid drugs. He was mainly in charge of pharmacodynamics in non-clinical studies. In addition, he managed PD marker measurement in clinical trials.